An open label randomized clinical trial of Indomethacin for mild and moderate hospitalised Covid-19 patients

Indomethacin, a non-steroidal anti-inflammatory drug (NSAID), has been presented as a broad-spectrum antiviral agent. This randomised clinical trial in a hospital setting evaluated the efficacy and safety of this drug in RT-PCR-positive coronavirus disease 2019 (COVID-19) patients. A total of 210 RT...

Descripción completa

Detalles Bibliográficos
Autores principales: Ravichandran, Rajan, Mohan, Surapaneni Krishna, Sukumaran, Suresh Kumar, Kamaraj, Devakumar, Daivasuga, Sumetha Suga, Ravi, Samson Oliver Abraham Samuel, Vijayaraghavalu, Sivakumar, Kumar, Ramarathnam Krishna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016692/
https://www.ncbi.nlm.nih.gov/pubmed/35440611
http://dx.doi.org/10.1038/s41598-022-10370-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016692/
https://www.ncbi.nlm.nih.gov/pubmed/35440611
http://dx.doi.org/10.1038/s41598-022-10370-1

Ejemplares similares